semaglutide vs terzepatide A new headline out about the investigational drug tirzepatide was published this week. This medicine is a dual GLP-1/GIP agonist. The average weight loss on the high dose over 72 weeks was MEDVi Under Review: Best GLP-1

Glutathione IV therapy at COEM is administered by a team of multidisciplinary physicians with extensive experience in environmental and functional medicine

Note: the effects are mild to modest as compared to injectables & topical retinoids

Maintains exercise performance: Hydration supports muscle function, endurance, and recovery, enabling you to stay active during a weight loss program

When taken in moderate, medically supervised doses , it is generally considered safe for most healthy adults

- L - : -

GLP-1 receptor agonists (often referred to as GLP-1 medications or simply GLP-1s) have changed the landscape of obesity and diabetes care